These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15482160)

  • 1. Control of influenza virus infection by immunity to conserved viral features.
    Epstein SL
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):627-38. PubMed ID: 15482160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping the memory of influenza viruses.
    Combadière B; Sibéril S; Duffy D
    Pathol Biol (Paris); 2010 Apr; 58(2):e79-86. PubMed ID: 20303671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.
    Kodihalli S; Kobasa DL; Webster RG
    Vaccine; 2000 May; 18(23):2592-9. PubMed ID: 10775793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
    Neu KE; Henry Dunand CJ; Wilson PC
    Curr Opin Immunol; 2016 Oct; 42():48-55. PubMed ID: 27268395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
    Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge.
    Wang X; Fu W; Yuan S; Yang X; Song Y; Liu L; Chi Y; Cheng T; Xing M; Zhang Y; Zhang C; Yang Y; Zhu C; Zhang X; Xiong S; Xu J; Zhou D
    Sci Rep; 2017 May; 7(1):1854. PubMed ID: 28500340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.
    McMurry JA; Johansson BE; De Groot AS
    Hum Vaccin; 2008; 4(2):148-57. PubMed ID: 18382131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
    Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
    Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
    Mullin J; Ahmed MS; Sharma R; Upile N; Beer H; Achar P; Puksuriwong S; Ferrara F; Temperton N; McNamara P; Lambe T; Gilbert SC; Zhang Q
    Vaccine; 2016 Mar; 34(14):1688-95. PubMed ID: 26902548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
    Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric influenza vaccination: understanding the T-cell response.
    Bodewes R; Fraaij PL; Osterhaus AD; Rimmelzwaan GF
    Expert Rev Vaccines; 2012 Aug; 11(8):963-71. PubMed ID: 23002977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of protection against influenza infection in humans--on the path to a universal vaccine?
    Li CK; Rappuoli R; Xu XN
    Curr Opin Immunol; 2013 Aug; 25(4):470-6. PubMed ID: 23948572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.
    Grødeland G; Bogen B
    Expert Rev Vaccines; 2015 Jun; 14(6):805-14. PubMed ID: 25818107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
    Muller RB; Maier R; Hoschler K; Zambon M; Ludewig B; Herrmann M; Schulze-Koops H; von Kempis J
    Clin Exp Rheumatol; 2013; 31(5):723-30. PubMed ID: 23806224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.